These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31635253)

  • 21. Is Helicobacter pylori eradication indicated in cirrhotic patients with peptic ulcer disease?
    Villalan R; Maroju NK; Kate V; Ananthakrishnan N
    Trop Gastroenterol; 2006; 27(4):166-8. PubMed ID: 17542294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased incidence of herpes zoster in adult patients with peptic ulcer disease: a population-based cohort study.
    Chen JY; Cheng TJ; Chang CY; Lan KM; Weng SF; Sheu MJ; Tseng SF; Hu ML
    Int J Epidemiol; 2013 Dec; 42(6):1873-81. PubMed ID: 24536094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
    Aalykke C; Lauritsen JM; Hallas J; Reinholdt S; Krogfelt K; Lauritsen K
    Gastroenterology; 1999 Jun; 116(6):1305-9. PubMed ID: 10348813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower Helicobacter pylori infection rate in chronic kidney disease and end-stage renal disease patients with peptic ulcer disease.
    Chang SS; Hu HY
    J Chin Med Assoc; 2014 Jul; 77(7):354-9. PubMed ID: 24907021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
    Hawkey CJ; Tulassay Z; Szczepanski L; van Rensburg CJ; Filipowicz-Sosnowska A; Lanas A; Wason CM; Peacock RA; Gillon KR
    Lancet; 1998 Sep; 352(9133):1016-21. PubMed ID: 9759744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Who Needs Gastroprotection in 2020?
    Kanno T; Moayyedi P
    Curr Treat Options Gastroenterol; 2020; 18(4):557-573. PubMed ID: 33199955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
    Chan FK; Sung JJ; Suen R; Lee YT; Wu JC; Leung WK; Chan HL; Lai AC; Lau JY; Ng EK; Chung SC
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1201-5. PubMed ID: 9882027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
    Cochrane Database Syst Rev; 2004; (2):CD004062. PubMed ID: 15106235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
    Cochrane Database Syst Rev; 2003; (4):CD004062. PubMed ID: 14584003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori-negative and non-steroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence: Multicenter follow-up study of peptic ulcers in Japan.
    Kanno T; Iijima K; Abe Y; Yagi M; Asonuma S; Ohyauchi M; Ito H; Koike T; Shimosegawa T
    Dig Endosc; 2016 Jul; 28(5):556-63. PubMed ID: 26866510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
    Hunt RH; Bazzoli F
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
    Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
    J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event.
    Hsiao FY; Tsai YW; Wen YW; Kuo KN; Tsai CR; Huang WF
    Pharmacotherapy; 2011 Mar; 31(3):239-47. PubMed ID: 21361733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
    Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
    Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers.
    Olafsson S; Hatlebakk JG; Berstad A
    Scand J Gastroenterol; 2002 Dec; 37(12):1386-94. PubMed ID: 12523587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.